-
IDENTIFYING RESPIRATORY VACCINE ATTRIBUTES DRIVING PATIENT PREFERENCE: AN AI-SUPPORTED TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS: A CASE STUDY OF VENTRAL HERNIAS IN ENGLAND AND THE ROLE OF TARGETED IMPLEMENTATION
Aug 11, 2026, 17:16 PM -
LONG-TERM CAREGIVING FOR SCHIZOPHRENIA IN CHINA: A QUALITATIVE STUDY OF BURDEN DIMENSIONS AND GAPS IN EXISTING ASSESSMENT
Aug 11, 2026, 17:16 PM -
DAGLIVE: AN AI-AUGMENTED INTERACTIVE APPLICATION FOR LIVING CAUSAL DIAGRAMS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND COST-UTILITY OF HIGH-DOSE INACTIVATED INFLUENZA VACCINE VERSUS STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN THE OLDER ADULTS AGED =65 YEARS IN POLAND
Aug 11, 2026, 17:16 PM -
THE INCIDENCE, MORTALITY, AND SURVIVAL OF MALIGNANT GASTRIC CANCER IN THE UNITED STATES: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) 2000-2023 DATABASE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUES OF POLICY INTERVENTIONS TO REDUCE ANTIMICROBIAL RESISTANCE USE: A SCOPING REVIEW OF MODEL-BASED ECONOMIC EVALUATION STUDIES
Aug 11, 2026, 17:16 PM -
COMPARATIVE CHANGE IN HBA1C AND WEIGHT OUTCOMES BETWEEN OBESE AND NON-OBESE ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH SGLT-2 INHIBITORS OR GLP-1 RECEPTOR AGONISTS
Aug 11, 2026, 17:16 PM -
ALTERNATIVE ACCESS MODELS FOR ANTI-OBESITY MEDICINES IN JAPAN UNDER REIMBURSEMENT CONSTRAINTS
Aug 11, 2026, 17:16 PM -
OPERATIONALIZING EUROPEAN UNION (EU) JOINT CLINICAL ASSESSMENT GUIDANCE (JCA) FOR INDIRECT TREATMENT COMPARISONS (ITCS): DEVELOPMENT AND APPLICATION OF A TRANSPARENCY FRAMEWORKASSESSMENTS
Aug 11, 2026, 17:16 PM -
ASSESSING THE ENVIRONMENTAL IMPACT OF HEALTH INTERVENTIONS IN HTA: A YEAR OF PROGRESS
Aug 11, 2026, 17:16 PM -
DETERMINATION OF MEANINGFUL WITHIN-PATIENT CHANGE THRESHOLDS (MWPC) FOR THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GASTRIC (FACT-GA) FROM STAR-221 TRIAL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF DENGUE VACCINATION IN BANGLADESH
Aug 11, 2026, 17:16 PM -
ARE WE READI FOR DISEASE-SPECIFIC REFERENCE CASE EXTENSIONS? LESSONS FROM NICE'S OBESITY FRAMEWORK
Aug 11, 2026, 17:16 PM -
ECONOMIC OPTIMIZATION OF POLYMYXIN B EXPOSURE TARGETS USING AN INTEGRATED PHARMACOMETRIC-PHARMACOECONOMIC SIMULATION FRAMEWORK
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC DISPARITIES ACROSS THE NON-SMALL CELL LUNG CANCER PRECISION ONCOLOGY PATHWAY: A SCOPING REVIEW AND EVIDENCE GAP MAP
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF CDST USE IN CROHN'S DISEASE: A FRENCH BUDGET IMPACT MODEL
Aug 11, 2026, 17:16 PM -
A BAYESIAN FRAMEWORK FOR LIFE CYCLE COST EFFECTIVENESS OF ATMPS: AN ONASEMNOGENE ABEPARVOVEC CASE STUDY
Aug 11, 2026, 17:16 PM -
BUDGET-IMPACT ANALYSIS OF TIVIDENOFUSP ALFA; A BLOOD-BRAIN BARRIER-CROSSING ENZYME REPLACEMENT THERAPY FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II IN PEDIATRIC PATIENTS WITH NEUROLOGIC SYMPTOMS
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPLICIT INCLUSION OF INFORMAL CARER SPILLOVERS IN HEALTH STATE VALUATION USING DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM
